Suppr超能文献

[第三代维甲酸R8923和全反式维甲酸对BALB/3T3 - A31细胞体外两阶段化学致癌作用的抑制效应]

[Inhibitory effect of a third generation retinoid R8923 and all-trans retinoic acid on two-stage chemical carcinogenesis of BALB/3T3-A31 cells in vitro].

作者信息

Guo C Y, Han R

机构信息

Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing.

出版信息

Zhonghua Zhong Liu Za Zhi. 1994 May;16(3):163-6.

PMID:7956690
Abstract

The inhibitory effect of a third generation retinoid R8923 and all-trans retinoic acid (RA) on malignant transformation of Balb/3T3-A31 cells induced by 3-methylcholanthrene (3-MCA) and 12-0-tetradecanoyl phorbol-13-acetate(TPA) was studied in paper. Malignant transformation of Balb/3T3-A31 cells was evaluated by scoring transformation foci and soft agar assay. Actively growing Balb/3T3-A31 cells (1.5 x 10(4) cells per 60-mm-diameter glass dish) were cultured in 5ml of Eagle's Minimum Essential Medium supplemented with 10 percent fetal bovine serum. Twenty-four hours after plating, the cells were treated with 3-MCA (2 micrograms/ml) for 72 hours. TPA was added into the medium at a concentration of 100 ng/ml for 2 weeks. Thirty-six days after cell plating, the transformation foci were counted and the soft agar assay of the cells isolated from each glass dish was performed. Results showed that there were 16.0 +/- 1.58 transformation foci/dish and the colony forming efficiency in soft agar assay was 138.6 +/- 14.47/10(3) cells in 3-MCA and TPA treated dishes (control group). When the cells were exposed to R8923 or RA (at a concentration of 10(-6) M), the transformation foci were 11.2 +/- 0.84 /dish and 9.2 +/- 1.10/dish respectively, and the corresponding colony forming efficiency values were 66.1 +/- 7.68/10(3) cells and 64.8 +/- 4.46/10(3) cells. They were significantly lower than that of the control group. These results demonstrated that R8923 and RA could effectively inhibit 3-MCA and TPA induced malignant transformation of Balb/3T3-A31 cells and suggested that R8923 is a potential drug for cancer chemoprevention.

摘要

本文研究了第三代维甲酸R8923和全反式维甲酸(RA)对3-甲基胆蒽(3-MCA)和12-O-十四烷酰佛波醇-13-乙酸酯(TPA)诱导的Balb/3T3-A31细胞恶性转化的抑制作用。通过对转化灶进行评分和软琼脂试验来评估Balb/3T3-A31细胞的恶性转化。将处于活跃生长状态的Balb/3T3-A31细胞(每60毫米直径玻璃培养皿中1.5×10⁴个细胞)接种于5毫升补充有10%胎牛血清的伊格尔最低必需培养基中培养。接种24小时后,用3-MCA(2微克/毫升)处理细胞72小时。然后向培养基中加入浓度为100纳克/毫升的TPA,处理2周。细胞接种36天后,计数转化灶,并对从每个玻璃培养皿中分离出的细胞进行软琼脂试验。结果显示,在3-MCA和TPA处理的培养皿(对照组)中,每个培养皿有16.0±1.58个转化灶,软琼脂试验中的集落形成效率为138.6±14.47/10³个细胞。当细胞暴露于R8923或RA(浓度为10⁻⁶摩尔/升)时,转化灶分别为11.2±0.84个/培养皿和9.2±1.10个/培养皿,相应的集落形成效率值分别为66.1±7.68/10³个细胞和64.8±4.46/10³个细胞。它们显著低于对照组。这些结果表明,R8923和RA可有效抑制3-MCA和TPA诱导的Balb/3T3-A31细胞恶性转化,并提示R8923是一种潜在的癌症化学预防药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验